Back
Sarepta Therapeutics Stock Price Chart
Apple just traded your privacy for $20 Billion
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
49
SRPT
Sarepta Therapeutics
Last Price:
$74.08
Seasonality Move:
14.66%
7 Day Trial
ALL ACCESS PASS
$
7
Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.
Sarepta Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 87.22 | Sell |
| 20-day SMA: | 97.87 | Sell |
| 50-day SMA: | 108.64 | Sell |
| 200-day SMA: | 125.16 | Sell |
| 8-day EMA: | 84.58 | Sell |
| 20-day EMA: | 94.74 | Sell |
| 50-day EMA: | 105.16 | Sell |
| 200-day EMA: | 118.38 | Sell |
Sarepta Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -8.7 | Sell |
| Relative Strength Index (14 RSI): | 27.9 | Sell |
| Chaikin Money Flow: | -367389 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (88.59 - 111.17) | Sell |
| Bollinger Bands (100): | (103.29 - 127.87) | Sell |
Sarepta Therapeutics Technical Analysis
| Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sarepta Therapeutics Stock
Is Sarepta Therapeutics Stock a Buy?
-
Sarepta Therapeutics share price is 74.10 while SRPT 8-day simple moving average is 87.22, which is a Sell signal.
-
The stock price of SRPT is 74.10 while Sarepta Therapeutics 20-day SMA is 97.87, which makes it a Sell.
-
Sarepta Therapeutics 50-day simple moving average is 108.64 while SRPT share price is 74.10, making it a Sell technically.
-
SRPT stock price is 74.10 and Sarepta Therapeutics 200-day simple moving average is 125.16, creating a Sell signal.
SRPT Technical Analysis vs Fundamental Analysis
Sell
49
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy or a Sell?
-
Sarepta Therapeutics stock is rated a SellThe current Sarepta Therapeutics [SRPT] share price is $74.10. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
Sarepta Therapeutics Stock Info
Market Cap:
7.2B
Price in USD:
74.10
Share Volume:
2.6M
Sarepta Therapeutics 52-Week Range
52-Week High:
173.25
52-Week Low:
73.06
Sell
49
Sarepta Therapeutics (SRPT)
is a Sell
Sarepta Therapeutics Share Price Forecast
-
What is the Sarepta Therapeutics stock price today?The Sarepta Therapeutics stock price is 74.10 USD today.
-
Will SRPT stock go up or go down?Sarepta Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Sarepta Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sarepta Therapeutics is overvalued.
Is Sarepta Therapeutics Stock a Buy?
-
Sarepta Therapeutics share price is 74.10 while SRPT 8-day exponential moving average is 84.58, which is a Sell signal.
-
The stock price of SRPT is 74.10 while Sarepta Therapeutics 20-day EMA is 94.74, which makes it a Sell.
-
Sarepta Therapeutics 50-day exponential moving average is 105.16 while SRPT share price is 74.10, making it a Sell technically.
-
SRPT stock price is 74.10 and Sarepta Therapeutics 200-day simple moving average is 118.38, creating a Sell signal.
Fundamental Analysis of Sarepta Therapeutics
Is Sarepta Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.
Technical Analysis of Sarepta Therapeutics
Should I short Sarepta Therapeutics stock?
-
SRPT Moving Average Covergence Divergence (MACD) indicator is -8.7, suggesting Sarepta Therapeutics is a Sell
-
Sarepta Therapeutics Relative Strength Index (RSI) is 27.9, which suggest Sarepta Therapeutics is oversold
-
The Bollinger Bands (25) for Sarepta Therapeutics is (88.59 - 111.17), which suggest Sarepta Therapeutics is a Sell
-
The Bollinger Bands (100) for Sarepta Therapeutics is (103.29 - 127.87), which suggest Sarepta Therapeutics is a Sell
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.